Diagnostic performance of endoscopy for subsquamous extension of superficial adenocarcinoma of the esophagogastric junction

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA A Cancer J Clin. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Buas MF, Vaughan TL. Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol. 2013;23(1):3–9.
   PubMed Web of Science ®Google Scholar
• Kusano C, Gotoda T, Khor CJ, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol. 2008;23(11):1662–1665.
   PubMed Web of Science ®Google Scholar
• Imamura Y, Watanabe M, Toihata T, et al. Recent incidence trend of surgically resected esophagogastric junction adenocarcinoma and microsatellite instability status in Japanese patients. Digestion. 2019;99(1):6–13.
   PubMed Web of Science ®Google Scholar
• Kakushima N, Yahagi N, Fujishiro M, et al. Efficacy and safety of endoscopic submucosal dissection for tumors of the esophagogastric junction. Endoscopy. 2006;38(2):170–174.
   PubMed Web of Science ®Google Scholar
• Yoshinaga S, Gotoda T, Kusano C, et al. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction. Gastrointest Endosc. 2008;67(2):202–209.
   PubMed Web of Science ®Google Scholar
• Hirasawa K, Kokawa A, Oka H, et al. Superficial adenocarcinoma of the esophagogastric junction: long-term results of endoscopic submucosal dissection. Gastrointest Endosc. 2010;72(5):960–966.
   PubMed Web of Science ®Google Scholar
• Imai K, Kakushima N, Tanaka M, et al. Validation of the application of the Japanese curative criteria for superficial adenocarcinoma at the esophagogastric junction treated by endoscopic submucosal dissection: a long-term analysis. Surg Endosc. 2013;27(7):2436–2445.
   PubMed Web of Science ®Google Scholar
• Yamada M, Oda I, Nonaka S, et al. Long-term outcome of endoscopic resection of superficial adenocarcinoma of the esophagogastric junction. Endoscopy. 2013;45(12):992–996.
   PubMed Web of Science ®Google Scholar
• Omae M, Fujisaki J, Horiuchi Y, et al. Safety, efficacy, and long-term outcomes for endoscopic submucosal dissection of early esophagogastric junction cancer. Gastric Cancer. 2013;16(2):147–154.
   PubMed Web of Science ®Google Scholar
• Hoteya S, Matsui A, Iizuka T, et al. Comparison of the clinicopathological characteristics and results of endoscopic submucosal dissection for esophagogastric junction and non-junctional cancers. Digestion. 2013;87(1):29–33.
   PubMed Web of Science ®Google Scholar
• Gong EJ, Kim do H, So H, et al. Clinical outcomes of endoscopic submucosal dissection for adenocarcinoma of the esophagogastric junction. Dig Dis Sci. 2016;61(9):2666–2673.
   PubMed Web of Science ®Google Scholar
• Gong EJ, Kim DH, Ahn JY, et al. Comparison of long-term outcomes of endoscopic submucosal dissection and surgery for esophagogastric junction adenocarcinoma. Gastric Cancer. 2017;20(Suppl 1):84–91.
   PubMed Web of Science ®Google Scholar
• Nagami Y, Ominami M, Otani K, et al. Endoscopic submucosal dissection for adenocarcinomas of the esophagogastric junction. Digestion. 2018;97(1):38–44.
   PubMed Web of Science ®Google Scholar
• Abe S, Ishihara R, Takahashi H, et al. Long-term outcomes of endoscopic resection and metachronous cancer after endoscopic resection for adenocarcinoma of the esophagogastric junction in Japan. Gastrointest Endosc. 2019;89(6):1120–1128.
   PubMed Web of Science ®Google Scholar
• Goda K, Singh R, Oda I, et al. Current status of endoscopic diagnosis and treatment of superficial Barrett’s adenocarcinoma in Asia-Pacific region. Dig Endosc. 2013;25:146–150.
   PubMed Web of Science ®Google Scholar
• Yamagata T, Hirasawa D, Fujita N, et al. Efficacy of acetic acid-spraying method in diagnosing extension of Barrett’s cancer under the squamous epithelium. Dig Endosc. 2012;24(5):309–314.
   PubMed Web of Science ®Google Scholar
• Omae M, Fujisaki J, Shimizu T, et al. Magnifying endoscopy with narrow-band imaging findings in the diagnosis of Barrett’s esophageal adenocarcinoma spreading below squamous epithelium. Dig Endosc. 2013;25:162–167.
   PubMed Web of Science ®Google Scholar
• Takahashi A, Oyama T. Endoscopic diagnosis of subsquamous invasion of adenocarcinoma in short-segment Barrett’s esophagus. Dig Endosc. 2017;29:38–39.
   PubMed Web of Science ®Google Scholar
• Nagami Y, Machida H, Shiba M, et al. Clinical efficacy of endoscopic submucosal dissection for adenocarcinomas of the esophagogastric junction. Endosc Int Open. 2014;2(1):E15–E20.
   PubMedGoogle Scholar
• Takada K, Yabuuchi Y, Yamamoto Y, et al. Predicting the depth of superficial adenocarcinoma of the esophagogastric junction. J Gastroenterol Hepatol. 2022;37(2):363–370.
   PubMed Web of Science ®Google Scholar
• Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998;85(11):1457–1459.
   PubMed Web of Science ®Google Scholar
• Nomura S, Ida K, Terao S, et al. Endoscopic diagnosis of gastric mucosal atrophy: multicenter prospective study. Dig Endosc. 2014;26(6):709–719.
   PubMed Web of Science ®Google Scholar
• Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;1(03):87–97.
   Google Scholar
• Kuwano H, Nishimura Y, Oyama T, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan esophageal society. Esophagus. 2015;12(1):1–30.
   PubMed Web of Science ®Google Scholar
• Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer English Edn. 2011;14:101–112.
   PubMed Web of Science ®Google Scholar
• Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013;48(3):452–458.
   PubMed Web of Science ®Google Scholar
• Wilkinson SP, Biddlestone L, Gore S, et al. Regression of columnar-lined (Barrett’s) oesophagus with omeprazole 40 mg daily: results of 5 years of continuous therapy. Aliment Pharmacol Ther. 1999;13(9):1205–1209.
   PubMed Web of Science ®Google Scholar
• Amano Y, Kushiyama Y, Yuki T, et al. Predictors for squamous re-epithelialization of Barrett’s esophagus after endoscopic biopsy. J Gastroenterol Hepatol. 2007;22(6):901–907.
   PubMed Web of Science ®Google Scholar
• Bronner MP, Overholt BF, Taylor SL, et al. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett’s esophagus with high-grade dysplasia. Gastroenterology. 2009;136(1):56–64.
   PubMed Web of Science ®Google Scholar
• Uedo N, Yoshio T, Yoshinaga S, et al. Endoscopic gastric mucosal atrophy distinguishes the characteristics of superficial esophagogastric junction adenocarcinoma. Dig Endosc. 2017;29:26–36.
   PubMed Web of Science ®Google Scholar
• Matsuno K, Ishihara R, Ohmori M, et al. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma. J Gastroenterol. 2019;54(9):784–791.
   PubMed Web of Science ®Google Scholar
• Manabe N, Matsueda K, Haruma K. Epidemiological review of gastroesophageal junction adenocarcinoma in Asian countries. Digestion. 2022;103(1):29–36.
   PubMed Web of Science ®Google Scholar